C12Y 105/01002
Pyrroline-5-carboxylate reductase
Official title: Pyrroline-5-carboxylate reductase (1.5.1.2)
C12Y105/01002 (Pyrroline-5-carboxylate reductase) appears on 7 US grants and 11 published applications in this corpus.
Search patents in C12Y- Granted patents
- 7
- Published applications
- 11
- Assignees
- 8
- Inventors
- 28
- Latest grant
- 7 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 2 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 2 | 2 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Microbial cells for spermidine production7 Oct 2025US 12,435,348 B2Chrysea Limited
- Proline auxotrophs4 May 2021US 10,995,316 B2Calysta, Inc.
- Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related disease by inhibition of natural antisense transcript to PYCR127 Feb 2018US 9,902,995 B2CuRNA, Inc.
- Muteins of the pyrroline-5-carboxylate reductase 19 Jan 2018US 9,862,986 B2Agency for Science, Technology and Research
- Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR15 Jul 2016US 9,382,543 B2CuRNA, Inc.
- Protein having l-proline efflux function, and use thereof15 Feb 2024US 2024/0052386 A1Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences
- Microbial cells for spermidine production27 Aug 2020US 2020/0270654 A1Chrysea Limited
- Inhibitors and antagonists of human pycr131 Jan 2019US 2019/0031773 A1Agency for Science, Technology and Research
- Proline auxotrophs19 Apr 2018US 2018/0105791 A1Calysta, Inc.
- Muteins of the pyrroline-5-carboxylate reductase 119 Apr 2018US 2018/0105860 A1
Most cited
By later US patents